BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28622710)

  • 1. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
    Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
    Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
    Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
    Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of clinical cellular immune markers in women with recurrent pregnancy loss.
    Lee SK; Na BJ; Kim JY; Hur SE; Lee M; Gilman-Sachs A; Kwak-Kim J
    Am J Reprod Immunol; 2013 Nov; 70(5):398-411. PubMed ID: 23656517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions.
    Graphou O; Chioti A; Pantazi A; Tsukoura C; Kontopoulou V; Guorgiadou E; Balafoutas C; Koussoulakos S; Margaritis LH; Varla-Leftherioti M
    Am J Reprod Immunol; 2003 Jan; 49(1):21-9. PubMed ID: 12733591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Th1/Th2 cell ratios in a pregnant woman with a history of RSA, secondary Sjögren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy.
    Kwak-Kim J; Lee SK; Gilman-Sachs A
    Am J Reprod Immunol; 2007 Oct; 58(4):325-9. PubMed ID: 17845202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
    Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
    J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th1/Th2 ratio.
    Azizi R; Ahmadi M; Danaii S; Abdollahi-Fard S; Mosapour P; Eghbal-Fard S; Dolati S; Kamrani A; Rahnama B; Mehdizadeh A; Jadidi-Niaragh F; Yousefi B; Yousefi M
    J Cell Physiol; 2019 Aug; 234(10):19039-19047. PubMed ID: 30924169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF.
    Winger EE; Reed JL; Ashoush S; El-Toukhy T; Ahuja S; Taranissi M
    Am J Reprod Immunol; 2011 Nov; 66(5):394-403. PubMed ID: 21623994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
    Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
    Yang X; Meng T
    J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.
    Ota K; Dambaeva S; Han AR; Beaman K; Gilman-Sachs A; Kwak-Kim J
    Hum Reprod; 2014 Feb; 29(2):208-19. PubMed ID: 24277747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity and cytokine production after in vitro immunoglobulin treatment of lymphocytes derived from pregnant women with or without risk for spontaneous abortion.
    Szereday L; Späth P; Szekeres-Bartho J
    Am J Reprod Immunol; 1999 Nov; 42(5):282-7. PubMed ID: 10584982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy.
    Kheshtchin N; Gharagozloo M; Andalib A; Ghahiri A; Maracy MR; Rezaei A
    Am J Reprod Immunol; 2010 Aug; 64(2):104-12. PubMed ID: 20331585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.
    Jafarzadeh S; Ahmadi M; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Kamrani A; Behrad B; Roshangar L; Jadidi-Niaragh F; Yousefi B; Mehdipour M; Farzadi L; Yousefi M
    J Cell Biochem; 2019 Apr; 120(4):5424-5434. PubMed ID: 30326143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions.
    Kwak JY; Kwak FM; Ainbinder SW; Ruiz AM; Beer AE
    Am J Reprod Immunol; 1996 Apr; 35(4):363-9. PubMed ID: 8739455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
    Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
    Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood.
    Yamada H; Morikawa M; Furuta I; Kato EH; Shimada S; Iwabuchi K; Minakami H
    Am J Reprod Immunol; 2003 Feb; 49(2):84-9. PubMed ID: 12765346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment.
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Dolati S; Farzadi L; Ghasemzadeh A; Hamdi K; Younesi V; Nouri M; Yousefi M
    Syst Biol Reprod Med; 2017 Dec; 63(6):350-359. PubMed ID: 29099629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.